Angiotech - Redefining Success™
  • Global Locations
  • Site Map
  • Home
  • About Us
    • Corporate Profile
    • Company History
    • Management Team
    • Corporate Alliances
    • Intellectual Property
  • Focus Markets
    • Focus Markets Overview
    • Wound Closure
  • Technology
    • Medical Devices
    • Technology Pipeline
    • Clinical Trials
    • Patient Education
    • Glossary
  • Investors
    • Investor Overview
    • Corporate Governance
    • Events & Webcasts
    • Quarterly Results
    • Annual Reports
    • SEC Filings
    • Stock Info & Quote
    • Covering Analysts
    • Request Information
  • News
    • Press Releases
    • Photos & Graphics
    • Awards & Accolades
    • Email Alerts
  • Careers
  • Contact Us

 Wound Closure

Print

Home › Focus Markets › Wound Closure

Angiotech’s wound closure group has extensive manufacturing and sales expertise, dating back over 100 years. Angiotech's direct sales force offers a specialized line of suture products for tissue approximation and ligation. These products are offered in a variety of absorbable and non-absorbable suture materials, possessing superior sharpness, penetration, and strength characteristics.

In addition to its specialized suture product lines, Angiotech launched its next generation in wound closure products in January 2007 with the Quill™ Self-Retaining System (SRS). The Quill™ SRS uses a patented barb design that eliminates the need for knots.

  • Read more about Quill™ SRS

Focus Markets

  • Wound Closure
    • Quill™ SRS

Quick Links

  • Events & Webcasts
  • Stock Quote/Chart
  • Latest Quarterly Results
  • Press Releases
  • Annual Reports

  • Terms of Use
  • Privacy Policy

© Copyright 2006. All Rights Reserved.